Designing medicines of the future
At PharmEnable Therapeutics, our mission is to develop innovative treatments for diseases with high unmet clinical need. With our scientist led, AI-enhanced approach, our aim is to create a drug discovery powerhouse with an asset-rich portfolio of small molecules.
We have a drug discovery pipeline of in-house projects and ongoing partnerships. We work across a range of disease areas where drug specificity is a significant challenge, such as cancer and neurological disease.
In particular, we specialize in drugging challenging targets, for example using our technology to tackle specific protein-protein interactions of major cancer targets.
Partner with us
We are delighted to partner with teams of complementary expertise to tackle challenging drug targets.